# Subject Preference for Scalp Psoriasis Treatment

> **NCT00438399** · PHASE3 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 219 (actual)

## Conditions studied

- Scalp Psoriasis

## Interventions

- **DRUG:** C. propionate - Corticosteroid 1
- **DRUG:** C. propionate- Corticosteroid 2
- **DRUG:** C. propionate -Corticosteroid 3
- **DRUG:** Corticosteroid 1- C. propionate
- **DRUG:** Corticosteroid 2 - C. propionate
- **DRUG:** Corticosteroid 3 - C. propionate

## Key facts

- **NCT ID:** NCT00438399
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2008-01
- **Final completion:** 2008-02
- **Target enrollment:** 219 (ACTUAL)
- **Last updated:** 2021-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00438399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00438399, "Subject Preference for Scalp Psoriasis Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00438399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*